FDA Warns Against Hydroxychloroquine But is Okay With Off Label Use of Puberty Blockers for Gender Dysphoria
1) While the FDA is putting out warnings on Hydroxychloroquine, they allow puberty blockers to be given to children as an "off label" use for “gender dysphoria” by a drug that was originally FDA approved in the early 90s for a made-up issue called c
Read more…
0 Replies
